POORLY managed sleep apnoea can lead to uncontrolled blood pressure - a little known underlying risk for millions of people's cardiovascular health, a new study in Nature journal has revealed.
Most at risk are those with wide-ranging variability in their night-to-night Obstructive Sleep Apnoea (OSA) severity which can be overlooked or misdiagnosed during standard clinical testing, the Flinders University-led research warned.
"Regardless of their overall OSA average severity, people with increased night-to-night variability in the amount of sleep apnoea are at a 50% to 70% increased likelihood of having uncontrolled hypertension and variable blood pressure - a confirmed risk factor for cardiovascular events, all-cause mortality, vascular organ damage, atrial fibrillation and dementia," explained lead author Dr Bastien Lechat.
"High variability in OSA severity is an independent clinical predictor of uncontrolled hypertension and has significant implications for identifying patients most at risk of cardiovascular harm."
OSA is a clinical sleep disorder characterised by repetitive upper airway collapse during sleep and is estimated to affect approximately one billion people globally.
The Flinders Health and Medical Research Institute (FHMRI) Sleep Health research is one of the first large-scale extended studies of OSA severity, made possible by using a novel under-mattress sleep sensor technology that allows for multi-night, in-home, non-invasive monitoring of sleep data from 12,287 adults over approximately 180 nights with about 30 repeat blood pressure tests.
"The findings reinforce recent evidence indicating there is considerable night-to-night variation in OSA severity for many people, which raises concerns clinically regarding OSA misdiagnosis," said senior Flinders University sleep researcher and FHMRI Sleep Health Director, Prof Danny Eckert.
"Therefore, there is considerable potential to incorporate new simplified monitoring approaches to aid current single-night diagnostics, which are labour intensive and costly."
The above article was sent to subscribers in Pharmacy Daily's issue from 28 Apr 23
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 28 Apr 23